Treatment of corneal ulcers and endophthalmitis caused by yeast fungi
- Authors: Kovaleva L.A.1, Krichevskaya G.I.1, Balackaya N.V.1, Markelova O.I.1
-
Affiliations:
- Helmholtz National Medical Research Center of Eye Diseases
- Issue: Vol 16, No 1 (2021)
- Pages: 31-38
- Section: Case reports
- URL: https://ruspoj.com/1993-1859/article/view/75808
- DOI: https://doi.org/10.17816/rpo2021-16-1-31-38
- ID: 75808
Cite item
Abstract
Aim: To analyze the pathogenesis, clinical features, and treatment algorithm of fungal corneal ulcer with endophthalmitis to increase medical alertness and reduce the unjustified use of antibacterial and corticosteroid therapy in corneal diseases of various etiologies, leading to the development of secondary ophthalmomycosis.
Results: The pathogenesis was analyzed, and the characteristic clinical symptoms of severe fungal corneal ulcer and endophthalmitis caused by Candida albicans were described. Intensive, long-term, unjustified antibacterial and corticosteroid therapy caused a prolonged course of herpetic corneal ulcer, as well as the addition of a secondary bacterial infection, and led to the development of severe corneal ulcer and fungal endophthalmitis in a 13-year-old child.
Conclusion: The required maximum medical alertness and early, accurate clinical differential diagnosis between bacterial and fungal corneal ulcer, as well as the rapid flow of ophthalmomycosis and false-negative results of sowing content conjunctival sac entail expansion of the range and quantity of antibacterial drugs used in the absence of positive dynamics of antibiotic therapy and an increased frequency of secondary fungal infection.
The clinical symptoms of a severe fungal corneal ulcer with endophthalmitis described in this report contribute to the early diagnosis of ophthalmomycosis before the type of pathogen is identified by laboratory methods, which makes it possible to start antifungal therapy earlier and avoid corneal perforation and eye loss. In most countries, due to the lack of an ocular form of antifungal drugs, for local treatment of corneal candidiasis, a 0.2% solution of fluconazole intended for intravenous administration is installed in the eyes.
Full Text

About the authors
Ludmila A. Kovaleva
Helmholtz National Medical Research Center of Eye Diseases
Author for correspondence.
Email: ulcer.64@mail.ru
ORCID iD: 0000-0001-6239-9553
SPIN-code: 1406-5609
MD, PhD
Russian Federation, MoscowGalina I. Krichevskaya
Helmholtz National Medical Research Center of Eye Diseases
Email: gkri@yandex.ru
ORCID iD: 0000-0001-7052-3294
SPIN-code: 6808-0922
MD, PhD
Russian Federation, MoscowNatalya V. Balackaya
Helmholtz National Medical Research Center of Eye Diseases
Email: balnat07@rambler.ru
ORCID iD: 0000-0001-8007-6643
SPIN-code: 4912-5709
MD, PhD
Russian Federation, MoscowOksana I. Markelova
Helmholtz National Medical Research Center of Eye Diseases
Email: levinaoi@mail.ru
ORCID iD: 0000-0002-8090-6034
SPIN-code: 6381-9851
resident
Russian Federation, MoscowReferences
- Skryabina YV, Astakhov YS, Konenkova YS, et al. Diagnosis and treatment of fungal keratitis. Part I. Ophthalmology Journal. 2018;11(3):63–73. (In Russ). doi: 10.17816/OV11363-73
- Keay LJ, Gower EW, Iovieno A, et al. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study. Ophthalmology. 2011;118(5):920–926. doi: 10.1016/j.ophtha.2010.09.011
- Krichevskaya GI, Kovaleva LA, Zyurnyayeva ID, et al. The Effectiveness of PCR in Diagnosis of Fungal Keratitis. Ophthalmology in Russia. 2020;17(4):824–829. (In Russ). doi: 10.18008/1816-5095-2020-4-824-829
- Delyagin VM, Melnikova MB, Pershin BS, et al. Fungal damage of eyes (diagnosis and treatment). Prakticheskaya meditsina. 2015;(2):100–105. (In Russ).
- Iskenderli VB. The importance of the etiological structure of causative agents in the development and maintenance of different clinical forms of ophthalmic mycosis living in Azerbaijan. Biomeditsina. 2018;(2):10–12. (In Russ).
- Poltanova TI, Belousova NY. Recurrence of fungal keratitis in corneal transplant. Kazan medical journal. 2018;99(1): 148-150. (In Russ). doi: 10.17816/KMJ2018-148
- Obrubov AS, Belskaia KI. Pharmacotherapy of fungal keratitis. Fyodorov journal of ophthalmic surgery. 2018;(1):98–102. (In Russ). doi: 10.25276/0235-4160-2018-1-98-102
- Astakhov YS, Skryabina YV, Konenkova YS, et al. Mycotic keratitis diagnosis and treatment. Ophthalmology journal. 2013;6(2):75–80. (In Russ). doi: 10.17816/OV2013275-80
- Peyman GA, Lee PJ, Seal DV. Endophthalmitis: diagnosis and treatment. London: Taylor & Francis; 2004. 278 p.
- Neroev VV, Katargina LA, Kovaleva LA, et al. Clinical aspects of bacterial corneal ulcer prolonged course, the role of herpes viruses in its pathogenesis, treatment. Ophthalmology in Russia. 2019;16(1S):40–44. (In Russ.) doi: 10.18008/1816-5095-2019-1S-40-44
- Kovaleva LA, Krichevskaya GI, Balackaya NV. Bacterial corneal ulcers, causes of prolonged course, tactics of treatment. Point of View. East – West. 2018;(4):51–53. (In Russ). doi: 10.25276/2410-1257-2018-4-51-53
- Neroev VV, Slepova OS, Kovaleva LA, Krichevskaya GI. Optimizing etiological diagnostics and improving the efficiency of treating centralized infectious corneal ulcers. Russian Ophthalmological Journal. 2017;10(3):56–61. (In Russ). doi: 10.21516/2072-0076-2017-10-3-56-61
- Patent RUS №2623069. 2016. Byul. №34. Neroev VV, Kovaleva LA, Krichevskaya GI. Sposob opredeleniya pokazanii k provedeniyu protivogerpeticheskoi terapii pri tsentral’nykh bakterial’nykh yazvakh rogovitsy s zatyazhnym techeniem. Available from: http://www.findpatent.ru/patent/262/2623069.html (In Russ).
- Behrens-Baumann W. Mycosis of the eye and its adnexa. Developments in ophthalmology, Vol. 32. Basel: S. Karger AG; 1999. 201 p. doi: 10.1159/isbn.978-3-318-00462-5
- Manzouri B, Vafidis GC, Wyse R. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother. 2001;2(11): 1849–1857. doi: 10.1517/14656566.2.11.1849
Supplementary files
